Ruti Alon: A New Milestone in the Fight Against Pancreatic Cancer
Alpha Tau has completed enrollment in its multicenter IMPACT pilot study evaluating Alpha DaRT® in combination with standard first‑line chemotherapy in patients with newly diagnosed, unresectable locally advanced or metastatic pancreatic cancer.
Evidence level: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.